bethanechol has been researched along with Injuries, Radiation in 2 studies
Bethanechol: A slowly hydrolyzing muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, HEART RATE changes, and BRONCHIAL SPASM.
bethanechol : The carbamic acid ester of 2-methylcholine. A slowly hydrolysed muscarinic agonist with no nicotinic effects, it is used as its chloride salt to increase smooth muscle tone, as in the gastrointestinal tract following abdominal surgery, treatment of gastro-oesophageal reflux disease, and as an alternative to catheterisation in the treatment of non-obstructive urinary retention.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study suggests that bethanechol chloride therapy may be effective in patients with xerostomia and hyposalivation." | 9.41 | Efficacy of bethanechol chloride in the treatment of radiation-induced xerostomia in patients with head and neck cancer: A systematic review and meta-analysis. ( Abreu Alves, F; Azeredo Alves Antunes, L; Baena Elchin, C; da Graça Pinto, H; Moral Nakamura, D; Pena Coto, N; Thomazotti Berard, L, 2023) |
| "The present study suggests that bethanechol chloride therapy may be effective in patients with xerostomia and hyposalivation." | 5.41 | Efficacy of bethanechol chloride in the treatment of radiation-induced xerostomia in patients with head and neck cancer: A systematic review and meta-analysis. ( Abreu Alves, F; Azeredo Alves Antunes, L; Baena Elchin, C; da Graça Pinto, H; Moral Nakamura, D; Pena Coto, N; Thomazotti Berard, L, 2023) |
| "The aim of this study was to verify whether the use of bethanechol during radiotherapy (RT) for head and neck cancer (HNC) prevents radiation-induced xerostomia and salivary flow reduction." | 5.12 | A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer. ( Aboud, CG; Carvalho, AL; Coelho, Mde M; Freire, AR; Jham, BC; Teixeira, IV, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moral Nakamura, D | 1 |
| da Graça Pinto, H | 1 |
| Baena Elchin, C | 1 |
| Thomazotti Berard, L | 1 |
| Abreu Alves, F | 1 |
| Azeredo Alves Antunes, L | 1 |
| Pena Coto, N | 1 |
| Jham, BC | 1 |
| Teixeira, IV | 1 |
| Aboud, CG | 1 |
| Carvalho, AL | 1 |
| Coelho, Mde M | 1 |
| Freire, AR | 1 |
1 review available for bethanechol and Injuries, Radiation
| Article | Year |
|---|---|
Efficacy of bethanechol chloride in the treatment of radiation-induced xerostomia in patients with head and neck cancer: A systematic review and meta-analysis.
Topics: Bethanechol; Head and Neck Neoplasms; Humans; Radiation Injuries; Salivary Glands; Sexually Transmit | 2023 |
1 trial available for bethanechol and Injuries, Radiation
| Article | Year |
|---|---|
A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer.
Topics: Adult; Aged; Bethanechol; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Stagi | 2007 |